Bone Biologics Corporation — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c2dfc61-8b87-4560-bfcb-c65996fd8479/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $1.1B | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008887 |
| FY 2019 | $1.1B | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004977 |
| FY 2018 | $1.1B | 2007-10-18 – 2019-03-31 | evidence 0001493152-19-006965 |
| FY 2017 | $1.1B | 2007-10-18 – 2018-03-31 | evidence 0001493152-18-006922 |
| FY 2016 | $1.1B | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-008676 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Bone Biologics Corporation — all facts · Net Income · Operating Income